Tert-butyl undec-10-enoate

CAS No. 93757-41-6

Tert-butyl undec-10-enoate( —— )

Catalog No. M37460 CAS No. 93757-41-6

Tert-butyl undec-10-enoate (Tert-Butyl 10-undecenoate) is an organic synthesis intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 53 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tert-butyl undec-10-enoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tert-butyl undec-10-enoate (Tert-Butyl 10-undecenoate) is an organic synthesis intermediate.
  • Description
    Tert-butyl undec-10-enoate (Tert-Butyl 10-undecenoate) is an organic synthesis intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93757-41-6
  • Formula Weight
    240.38
  • Molecular Formula
    C15H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)CCCCCCCCC=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tulathromycin B

    Tulathromycin B (CP 547272) is an isomer of Tulathromycin (a macrolide antibiotic).

  • ACTH 22-39

    ACTH (22-39) is an adrenocorticotropic hormone (ACTH) fragment and it is the 22-39 sequence of ACTH.

  • [Leu144,Arg147]-Myel...

    [Leu144,Arg147]-PLP (139-151) is a mutant peptide fragment of myelin proteolipid protein (PLP), with the tryptophan and histidine at positions 144 and 147 respectively replaced by leucine and arginine. [Leu144,Arg147]-PLP (139-151) also serves as a T cell receptor (TCR) antagonist for encephalitogenic Th1 clones, blocking their activation in vitro. Furthermore, [Leu144,Arg147]-PLP (139-151) can inhibit the development of experimental autoimmune encephalomyelitis (EAE).